13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q1 2016. See the latest, Q3 2026 →
Reported value
$6.92B
First quarter on file
Positions
36
First quarter on file
Top 10
79.9%
of the value
Est. gain
—
Nothing to compare
Est. return
—
Nothing to compare
Positions as of Mar 31, 2016, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
Each tile is a position, sized by its share. Striped tiles are options.
E M C Corp Mass20%
Cheniere Energy Inc15%
Viasat Inc12%
Antero Res Corp7.7%
Allergan Plc6.7%
Pbf Energy Inc5.1%
PayPal3.9%Innoviva Inc3.6%
Twenty First Centy Fox Inc3.1%
Twenty First Centy Fox Inc3.0%
Olin Corp2.7%
12 others2.4%
Theravance Biopharma Inc1.8%
Keryx Biopharmaceuticals Inc1.7%
Vmware Inc1.7%
Veritiv Corp1.6%
Atara Biotherapeutics Inc1.5%
Forward Pharma A/S1.3%
Novagold Res Inc1.1%
Chipmos Tech Bermuda Ltd0.9%
Klx Inc0.9%
0.8%
0.6%
0.6%
0.5%
Holdings
As of Mar 31, 2016, the first quarter on file.
| Holding | Value | |||||
|---|---|---|---|---|---|---|
| E M C Corp MassCOM | 20.0% | $1.38B | ||||
| Cheniere Energy IncCOM NEW | 14.6% | $1.01B | ||||
| Viasat IncCOM | 12.2% | $847.5M | ||||
| Antero Res CorpCOM | 7.7% | $534.9M | ||||
| Allergan PlcSHS | 6.7% | $461.4M | ||||
| Pbf Energy IncCL A | 5.1% | $353.3M | ||||
| PayPalCOM | 3.9% | $272.5M | ||||
| Innoviva IncCOM | 3.6% | $249.5M | ||||
| Twenty First Centy Fox IncCL A | 3.1% | $214.6M | ||||
| Twenty First Centy Fox IncCL B | 3.0% | $205.2M | ||||
| Olin CorpCOM PAR $1 | 2.7% | $186.5M | ||||
| Theravance Biopharma IncCOM | 1.8% | $122.2M | ||||
| Keryx Biopharmaceuticals IncCOM | 1.7% | $120.4M | ||||
| Vmware IncCL A COM | 1.7% | $117.8M | ||||
| Veritiv CorpCOM | 1.6% | $113.4M | ||||
| Atara Biotherapeutics IncCOM | 1.5% | $102.0M | ||||
| Forward Pharma A/SSPONSORED ADR | 1.3% | $91.2M | ||||
| Novagold Res IncCOM NEW | 1.1% | $75.6M | ||||
| Chipmos Tech Bermuda LtdSHS | 0.94% | $65.2M | ||||
| Klx IncCOM | 0.93% | $64.3M | ||||
| Sunedison Semiconductor LtdSHS | 0.78% | $54.3M | ||||
| American Intl Group Inc*W EXP 01/19/202 | 0.57% | $39.7M | ||||
| Silver Run Acquisition CorpUNIT 99/99/9999T | 0.56% | $38.8M | ||||
| Theravance IncNOTE 2.125% 1/1 | 0.55% | $37.8M | ||||
| Biotie Therapies OyjSPONSORED ADR | 0.53% | $36.8M | ||||
| Total 36 positions | 100% | $6.92B |
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |